Greenwich LifeSciences Ownership 2024 | Who Owns Greenwich LifeSciences Now?
Institutional Ownership
1.54%
Insider Ownership
54.00%
Retail Ownership
44.45%
Institutional Holders
10.00
Greenwich LifeSciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 2.40% | 0.00% | 308,909 | 252,450 | 447.14% | 5,331,769 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.09% | 0.00% | 268,168 | 45,066 | 20.20% | 4,628,579 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 0.00% | 127,689 | 69,445 | 119.23% | 2,204,159 | Jun 30, 2024 |
| CREDIT AGRICOLE S A | 0.68% | 0.01% | 87,000 | 87,000 | 100.00% | 1,501,620 | Jun 30, 2024 |
| STATE STREET CORP | 0.53% | 0.00% | 68,403 | 55,401 | 426.10% | 1,180,636,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.29% | 0.00% | 36,900 | -600 | -1.60% | 636,894 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.19% | 0.00% | 24,320 | 3,105 | 14.64% | 419,763,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.14% | 0.00% | 18,454 | 18,454 | 100.00% | 318,516 | Jun 30, 2024 |
| MAN GROUP PLC | 0.13% | 0.00% | 16,650 | 5,285 | 46.50% | 287,379 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.12% | 0.00% | 15,295 | 15,295 | 100.00% | 263,991 | Jun 30, 2024 |
| MORGAN STANLEY | 0.05% | - | 7,053 | 823 | 13.21% | 121,735 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.05% | 0.00% | 6,799 | 6,799 | 100.00% | 117,345 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.05% | - | 6,328 | 693 | 12.30% | 109,222 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.05% | 0.00% | 6,000 | 6,000 | 100.00% | 104,000 | Jun 30, 2024 |
| STRS OHIO | 0.04% | 0.00% | 4,800 | 4,800 | 100.00% | 82,848,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 3,212 | 3,212 | 100.00% | 55,471 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.02% | - | 2,548 | -3,124 | -55.08% | 43,978 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 2,022 | 2,022 | 100.00% | 35,000 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 1,911 | 1,870 | 4560.98% | 32,984 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 1,807 | 1,405 | 349.50% | 31,189 | Jun 30, 2024 |
Greenwich LifeSciences's largest institutional shareholder is BLACKROCK INC., holding 2.40% of the company's total share outstanding, currently valued at $5.33M. The top 10 institutional shareholders own together 7.56% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CREDIT AGRICOLE S A | 0.68% | 0.01% | 87,000 | 87,000 | 100.00% | 1,501,620 | Jun 30, 2024 |
| FOUNDERS CAPITAL MANAGEMENT | 0.00% | 0.01% | 500 | - | - | 8,630 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.29% | 0.00% | 36,900 | -600 | -1.60% | 636,894 | Jun 30, 2024 |
| MAN GROUP PLC | 0.13% | 0.00% | 16,650 | 5,285 | 46.50% | 287,379 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.00% | 0.00% | 585 | 585 | 100.00% | 10,097 | Jun 30, 2024 |
| STRS OHIO | 0.04% | 0.00% | 4,800 | 4,800 | 100.00% | 82,848,000 | Jun 30, 2024 |
| WASHINGTON TRUST ADVISORS, INC. | 0.00% | 0.00% | 200 | - | - | 3,452 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 3,212 | 3,212 | 100.00% | 55,471 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 0.00% | 127,689 | 69,445 | 119.23% | 2,204,159 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.05% | 0.00% | 6,000 | 6,000 | 100.00% | 104,000 | Jun 30, 2024 |
| BLACKROCK INC. | 2.40% | 0.00% | 308,909 | 252,450 | 447.14% | 5,331,769 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.05% | 0.00% | 6,799 | 6,799 | 100.00% | 117,345 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.09% | 0.00% | 268,168 | 45,066 | 20.20% | 4,628,579 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.19% | 0.00% | 24,320 | 3,105 | 14.64% | 419,763,000 | Jun 30, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | 0.00% | 0.00% | 88 | - | - | 1,519 | Jun 30, 2024 |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 0.00% | 0.00% | 51 | - | - | 880 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.14% | 0.00% | 18,454 | 18,454 | 100.00% | 318,516 | Jun 30, 2024 |
| STATE STREET CORP | 0.53% | 0.00% | 68,403 | 55,401 | 426.10% | 1,180,636,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.12% | 0.00% | 15,295 | 15,295 | 100.00% | 263,991 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 207 | 207 | 100.00% | 4,000 | Jun 30, 2024 |
The largest Greenwich LifeSciences shareholder by % of total assets is CREDIT AGRICOLE S A. The company owns 87.00K shares of Greenwich LifeSciences (GLSI), representing 0.01% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 2.40% | 0.00% | 308,909 | 252,450 | 447.14% | 5,331,769 | Jun 30, 2024 |
| CREDIT AGRICOLE S A | 0.68% | 0.01% | 87,000 | 87,000 | 100.00% | 1,501,620 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 0.00% | 127,689 | 69,445 | 119.23% | 2,204,159 | Jun 30, 2024 |
| STATE STREET CORP | 0.53% | 0.00% | 68,403 | 55,401 | 426.10% | 1,180,636,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.09% | 0.00% | 268,168 | 45,066 | 20.20% | 4,628,579 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.14% | 0.00% | 18,454 | 18,454 | 100.00% | 318,516 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.12% | 0.00% | 15,295 | 15,295 | 100.00% | 263,991 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.05% | 0.00% | 6,799 | 6,799 | 100.00% | 117,345 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.05% | 0.00% | 6,000 | 6,000 | 100.00% | 104,000 | Jun 30, 2024 |
| MAN GROUP PLC | 0.13% | 0.00% | 16,650 | 5,285 | 46.50% | 287,379 | Jun 30, 2024 |
| STRS OHIO | 0.04% | 0.00% | 4,800 | 4,800 | 100.00% | 82,848,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 3,212 | 3,212 | 100.00% | 55,471 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.19% | 0.00% | 24,320 | 3,105 | 14.64% | 419,763,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 2,022 | 2,022 | 100.00% | 35,000 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 1,911 | 1,870 | 4560.98% | 32,984 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 1,807 | 1,405 | 349.50% | 31,189 | Jun 30, 2024 |
| MORGAN STANLEY | 0.05% | - | 7,053 | 823 | 13.21% | 121,735 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.05% | - | 6,328 | 693 | 12.30% | 109,222 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 662 | 662 | 100.00% | 11,430 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.00% | 0.00% | 585 | 585 | 100.00% | 10,097 | Jun 30, 2024 |
As of Jun 30 2024, Greenwich LifeSciences's largest institutional buyer is BLACKROCK INC.. The company purchased 252.45K stocks of GLSI, valued at $5.33M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -63,811 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -41,505 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -17,317 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -15,165 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.02% | - | 2,548 | -3,124 | -55.08% | 43,978 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.29% | 0.00% | 36,900 | -600 | -1.60% | 636,894 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -530 | -100.00% | - | Jun 30, 2024 |
| GAME PLAN FINANCIAL ADVISORS, LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -110 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| FOUNDERS CAPITAL MANAGEMENT | 0.00% | 0.01% | 500 | - | - | 8,630 | Jun 30, 2024 |
| WASHINGTON TRUST ADVISORS, INC. | 0.00% | 0.00% | 200 | - | - | 3,452 | Jun 30, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | 0.00% | 0.00% | 88 | - | - | 1,519 | Jun 30, 2024 |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 0.00% | 0.00% | 51 | - | - | 880 | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 90 | - | - | 1,553 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 207 | 207 | 100.00% | 4,000 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 433 | 433 | 100.00% | 7,474 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 561 | 561 | 100.00% | 10,000 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.00% | 0.00% | 585 | 585 | 100.00% | 10,097 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 662 | 662 | 100.00% | 11,430 | Jun 30, 2024 |
As of Jun 30 2024, Greenwich LifeSciences's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -63.81K shares of GLSI, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CREDIT AGRICOLE S A | 0.68% | 0.01% | 87,000 | 87,000 | 100.00% | 1,501,620 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.14% | 0.00% | 18,454 | 18,454 | 100.00% | 318,516 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.12% | 0.00% | 15,295 | 15,295 | 100.00% | 263,991 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.05% | 0.00% | 6,799 | 6,799 | 100.00% | 117,345 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.05% | 0.00% | 6,000 | 6,000 | 100.00% | 104,000 | Jun 30, 2024 |
| STRS OHIO | 0.04% | 0.00% | 4,800 | 4,800 | 100.00% | 82,848,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 3,212 | 3,212 | 100.00% | 55,471 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 2,022 | 2,022 | 100.00% | 35,000 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 662 | 662 | 100.00% | 11,430 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.00% | 0.00% | 585 | 585 | 100.00% | 10,097 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 561 | 561 | 100.00% | 10,000 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 433 | 433 | 100.00% | 7,474 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 207 | 207 | 100.00% | 4,000 | Jun 30, 2024 |
Greenwich LifeSciences's largest new institutional shareholder by number of shares is CREDIT AGRICOLE S A, purchased 87.00K shares, valued at $1.50M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -63,811 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -41,505 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -17,317 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -15,165 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -530 | -100.00% | - | Jun 30, 2024 |
| GAME PLAN FINANCIAL ADVISORS, LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -110 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
Greenwich LifeSciences's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -63.81K shares, valued at -, as of undefined.
Greenwich LifeSciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.01% | 4,233 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 132,440 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 614 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 5,921 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 174,535 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 215,732 | -50,689 | -19.03% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,118 | - | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 46,435 | 2,988 | 6.88% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 2,391 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 316 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 2,671 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 1,489 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 73 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 1,119 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 107 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 602 | -5,656 | -90.38% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 2,141 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 800 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 132 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 39 | - | - | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 3,745 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 88 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 28,595 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 200 | - | - | Mar 28, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 13,691 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 134 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 22 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 1,515 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 538 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 24 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 4 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 783 | 134 | 20.65% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 9,502 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 590 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 162 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 3,500 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 27 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 451 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 13,450 | -352 | -2.55% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 954 | -184 | -16.17% | Mar 31, 2024 |
| Meeder Funds | 0.00% | 3 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 652 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 1,395 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 366 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 27 | -8 | -22.86% | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 680 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 729 | - | - | Feb 29, 2024 |
Greenwich LifeSciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 4.23K shares, compromising 0.01% of its total assets.
Greenwich LifeSciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -65.52% |
| 31 Mar, 24 | 29 | 11.54% |
| 31 Dec, 23 | 26 | 13.04% |
| 30 Sep, 23 | 23 | - |
| 30 Jun, 23 | 23 | -14.81% |
| 31 Mar, 23 | 27 | 28.57% |
| 31 Dec, 22 | 21 | 23.53% |
| 30 Sep, 22 | 17 | -32.00% |
| 30 Jun, 22 | 25 | -24.24% |
| 31 Mar, 22 | 33 | -5.71% |
| 31 Dec, 21 | 35 | -2.78% |
| 30 Sep, 21 | 36 | 20.00% |
| 30 Jun, 21 | 30 | 66.67% |
| 31 Mar, 21 | 18 | 28.57% |
| 31 Dec, 20 | 14 | 1300.00% |
| 30 Sep, 20 | 1 | - |
As of 30 Jun 24, 10 institutions are holding Greenwich LifeSciences's shares, representing a decrease of -65.52% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 198,322 | -69.24% |
| 31 Mar, 24 | 644,803 | 20.31% |
| 31 Dec, 23 | 535,932 | -0.26% |
| 30 Sep, 23 | 537,344 | -14.54% |
| 30 Jun, 23 | 628,750 | -24.02% |
| 31 Mar, 23 | 827,514 | 23.26% |
| 31 Dec, 22 | 671,383 | -15.31% |
| 30 Sep, 22 | 792,741 | -23.18% |
| 30 Jun, 22 | 1,031,942 | 10.82% |
| 31 Mar, 22 | 931,179 | 16.98% |
| 31 Dec, 21 | 795,986 | -2.42% |
| 30 Sep, 21 | 815,728 | 0.61% |
| 30 Jun, 21 | 810,815 | 212.38% |
| 31 Mar, 21 | 259,558 | 132.47% |
| 31 Dec, 20 | 111,654 | 40208.30% |
| 30 Sep, 20 | 277 | - |
Greenwich LifeSciences (GLSI) has 198.32K shares outstanding as of 30 Jun 24, down -69.24% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 1.54% | 6.12% |
| 31 Mar, 24 | 5.02% | 28.84% |
| 31 Dec, 23 | 4.17% | 23.85% |
| 30 Sep, 23 | 4.18% | 17.46% |
| 30 Jun, 23 | 4.89% | 11.80% |
| 31 Mar, 23 | 6.44% | 23.83% |
| 31 Dec, 22 | 5.20% | 13.60% |
| 30 Sep, 22 | 6.18% | 9.70% |
| 30 Jun, 22 | 7.99% | 15.72% |
| 31 Mar, 22 | 7.13% | 18.85% |
| 31 Dec, 21 | 6.15% | 15.54% |
| 30 Sep, 21 | 6.29% | 15.91% |
| 30 Jun, 21 | 6.29% | 152.92% |
| 31 Mar, 21 | 2.03% | 125.61% |
| 31 Dec, 20 | 1.27% | 12596343.75% |
| 30 Sep, 20 | 0.00% | - |
As of 30 Jun 24, Greenwich LifeSciences is held by 1.54% institutional shareholders, representing a 6.12% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 5 | -68.75% |
| 31 Mar, 24 | 16 | 6.67% |
| 31 Dec, 23 | 15 | 150.00% |
| 30 Sep, 23 | 6 | -40.00% |
| 30 Jun, 23 | 10 | -28.57% |
| 31 Mar, 23 | 14 | 40.00% |
| 31 Dec, 22 | 10 | 66.67% |
| 30 Sep, 22 | 6 | -66.67% |
| 30 Jun, 22 | 18 | 38.46% |
| 31 Mar, 22 | 13 | -35.00% |
| 31 Dec, 21 | 20 | - |
| 30 Sep, 21 | 20 | -20.00% |
| 30 Jun, 21 | 25 | 92.31% |
| 31 Mar, 21 | 13 | -7.14% |
| 31 Dec, 20 | 14 | 1300.00% |
| 30 Sep, 20 | 1 | - |
5 institutional shareholders have increased their position in GLSI stock as of 30 Jun 24 compared to 16 in the previous quarter (a -68.75% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -75.00% |
| 31 Mar, 24 | 4 | - |
| 31 Dec, 23 | 4 | -50.00% |
| 30 Sep, 23 | 8 | 14.29% |
| 30 Jun, 23 | 7 | -12.50% |
| 31 Mar, 23 | 8 | - |
| 31 Dec, 22 | 8 | - |
| 30 Sep, 22 | 8 | 33.33% |
| 30 Jun, 22 | 6 | -45.45% |
| 31 Mar, 22 | 11 | 37.50% |
| 31 Dec, 21 | 8 | 14.29% |
| 30 Sep, 21 | 7 | 133.33% |
| 30 Jun, 21 | 3 | - |
| 31 Mar, 21 | 3 | - |
| 31 Dec, 20 | - | - |
| 30 Sep, 20 | - | - |
1 institutional shareholders have reduced their position in GLSI stock as of 30 Jun 24 compared to 4 in the previous quarter (a -75.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 10 | -65.52% | 198,322 | -69.24% | 1.54% | 6.12% | 5 | -68.75% | 1 | -75.00% |
| 31 Mar, 24 | 29 | 11.54% | 644,803 | 20.31% | 5.02% | 28.84% | 16 | 6.67% | 4 | - |
| 31 Dec, 23 | 26 | 13.04% | 535,932 | -0.26% | 4.17% | 23.85% | 15 | 150.00% | 4 | -50.00% |
| 30 Sep, 23 | 23 | - | 537,344 | -14.54% | 4.18% | 17.46% | 6 | -40.00% | 8 | 14.29% |
| 30 Jun, 23 | 23 | -14.81% | 628,750 | -24.02% | 4.89% | 11.80% | 10 | -28.57% | 7 | -12.50% |
| 31 Mar, 23 | 27 | 28.57% | 827,514 | 23.26% | 6.44% | 23.83% | 14 | 40.00% | 8 | - |
| 31 Dec, 22 | 21 | 23.53% | 671,383 | -15.31% | 5.20% | 13.60% | 10 | 66.67% | 8 | - |
| 30 Sep, 22 | 17 | -32.00% | 792,741 | -23.18% | 6.18% | 9.70% | 6 | -66.67% | 8 | 33.33% |
| 30 Jun, 22 | 25 | -24.24% | 1,031,942 | 10.82% | 7.99% | 15.72% | 18 | 38.46% | 6 | -45.45% |
| 31 Mar, 22 | 33 | -5.71% | 931,179 | 16.98% | 7.13% | 18.85% | 13 | -35.00% | 11 | 37.50% |
| 31 Dec, 21 | 35 | -2.78% | 795,986 | -2.42% | 6.15% | 15.54% | 20 | - | 8 | 14.29% |
| 30 Sep, 21 | 36 | 20.00% | 815,728 | 0.61% | 6.29% | 15.91% | 20 | -20.00% | 7 | 133.33% |
| 30 Jun, 21 | 30 | 66.67% | 810,815 | 212.38% | 6.29% | 152.92% | 25 | 92.31% | 3 | - |
| 31 Mar, 21 | 18 | 28.57% | 259,558 | 132.47% | 2.03% | 125.61% | 13 | -7.14% | 3 | - |
| 31 Dec, 20 | 14 | 1300.00% | 111,654 | 40208.30% | 1.27% | 12596343.75% | 14 | 1300.00% | - | - |
| 30 Sep, 20 | 1 | - | 277 | - | 0.00% | - | 1 | - | - | - |
Greenwich LifeSciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of GLSI was made by Patel Snehal on Aug 08 2024, buying 2,000 shares at $13.81 per share (worth $27.62K).
Greenwich LifeSciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 5 | - | - |
| Q2 2024 | 2 | - | - |
| Q1 2024 | 6 | - | - |
| Q4 2023 | 7 | - | - |
| Q3 2023 | 7 | - | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 11 | - | - |
| Q4 2022 | 9 | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 20 | - | - |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 3 | 1 | 300.00% |
| Q2 2021 | 1 | - | - |
| Q4 2020 | 6 | 1 | 600.00% |
| Q3 2020 | 31 | 27 | 114.81% |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Greenwich LifeSciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 5 | - | - |
| Q2 2024 | 2 | - | - |
| Q1 2024 | 6 | - | - |
| Q4 2023 | 7 | - | - |
| Q3 2023 | 7 | - | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 11 | - | - |
| Q4 2022 | 9 | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 3 | - | - |
| Q2 2021 | 1 | - | - |
| Q4 2020 | 6 | - | - |
| Q3 2020 | 6 | - | - |
As of Q3 2024, Insider owners conducted 5 open market buy trades and 0 open market sell trades of Greenwich LifeSciences's stocks.
Greenwich LifeSciences Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| AVXL | Anavex Life Sciences Corp. |
| NXTC | NextCure, Inc. |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| VRPX | Virpax Pharmaceuticals, Inc. |
| PDSB | PDS Biotechnology Corporation |
| ACXP | Acurx Pharmaceuticals, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| IMMP | Immutep Limited |
| EYEN | Eyenovia, Inc. |
| MNOV | MediciNova, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| ENTX | Entera Bio Ltd. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
GLSI Ownership FAQ
Who Owns Greenwich LifeSciences?
Greenwich LifeSciences is owned by institutional shareholders (1.54%), insiders (54.00%), and public (44.45%). The largest institutional shareholder of Greenwich LifeSciences is BLACKROCK INC. (2.40% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.01% of total shares).
Who are the major institutional shareholders of Greenwich LifeSciences?
Greenwich LifeSciences's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CREDIT AGRICOLE S A, and STATE STREET CORP. The top five shareholders own together 6.69% of the company's share outstanding.
How many Greenwich LifeSciences shareholders are there?
As of Jun 2024, there are 10 institutional shareholders of Greenwich LifeSciences.
What percentage of Greenwich LifeSciences is owned by BLACKROCK INC?
BLACKROCK INC owns 308.91K shares of Greenwich LifeSciences, representing 2.40% of the company's total shares outstanding, valued at $5.33M (as of Jun 2024).
What percentage of Greenwich LifeSciences is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 268.17K shares of Greenwich LifeSciences (GLSI), compromising 2.09% of the company, valued at $4.63M.
What percentage of Greenwich LifeSciences is owned by GEODE CAPITAL MANAGEMENT, LLC?
GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Greenwich LifeSciences. The company owns 127.69K of the company's shares outstanding (worth $2.2M).